Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Jennifer Hellawell
Person

Jennifer Hellawell

Tracked across 1 events · 6 articles · First seen May 26, 2026 · Last active May 26, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 0
Tech
Arrowhead Presents Positive Plozasiran Data
Arrowhead Pharmaceuticals presented new positive clinical data for Plozasiran at the 94th European Atherosclerosis Society Congress. The data support the use of Plozasiran in patients with moderate-to-severe renal impairment or moderate hepatic impairment without dose…
Impact: Jennifer Hellawell, VP of Clinical Development at Arrowhead Pharmaceuticals, presented the data on plozasiran's pharmacokinetics, pharmacodynamics, and safety in patients with renal or hepatic impairment.
May 26, 2026 · 6 articles
NEWSDESK
Track Jennifer Hellawell live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.